SPONSOR
Daewoong Pharmaceutical Co. LTD.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: Autoimmune DiseasesDiabetes Mellitus, Type 2Idiopathic Pulmonary FibrosisHealthy Subjects
NCT06736587 Phase 1
Recruiting
A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers
Autoimmune Diseases
NCT06647888
Recruiting
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Diabetes Mellitus, Type 2
NCT05389215 Phase 2
Recruiting
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Idiopathic Pulmonary Fibrosis
NCT07144176 Phase 1
Recruiting
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
Healthy Subjects